Addyi Tablet, Film Coated
Product Images NDC 58604-214

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Addyi (NDC 58604-214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sprout Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Addycarton New

Addycarton New
This appears to be a label or packaging information for a medication called "flibanserin" tablets in 100mg dosage. It instructs to avoid coating a certain area on the tablets and to store them at a temperature of 25°C. The label also includes the medication code and quantity of 30 tablets.*
FDA Label Image

Addyibottle New

Addyibottle New
This is a medication called EleeV (fibanserin) that comes in 30 tablets of 100mg each. The recommended dosage is to take one tablet daily at bedtime. The medication should be stored at 25°C (77°F) and the accompanying medication guide should be dispensed to each patient. Additionally, it is important to keep the medication out of reach of children.*
FDA Label Image

Addyibottle

Addyibottle
This is a medication guide for Flibanserin tablets, manufactured by Sprout Pharmaceuticals. The tablets contain 100mg of Flibanserin and the recommended dosage is once a day at bedtime. The medication guide should be provided to each patient by the pharmacist. The tablets come in 30-tablet packaging and should be stored at 25°C. Expiry and lot numbers are not available.*
FDA Label Image

Addyicarton.jpg (Addyicarton)

Addyicarton.jpg (Addyicarton)
This is a medication packaging for Addyi (flibanserin) tablets. It contains 100mg tablets and must be taken once daily at bedtime. The tablets should be stored at 25°C (17°F). The packaging includes a medication guide for each patient. There is a "NO COATING AREA" indicated on the packaging.*
FDA Label Image
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
The text describes a graph showing the plasma concentration-time profile for Flibanserin in healthy female subjects after a single oral dose of 100 mg. The graph shows mean and standard deviation values on a linear scale for plasma Flibanserin concentration at different time points.*
FDA Label Image

Structural Formula (Structuralformula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.